Additionally, while we analyzed the main ApoC-III variants, we did not investigate other SNPs such as PNPLA3, TM6SF2, GCKR, MBOAT7, or HSD17B13, which are extensively recognized for their significant contributions to MASLD susceptibility and progression. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.